Casasampere, Carneros, Roda and colleagues published an approach in Nature Communications that extends the small molecule chimera strategy to directly exploit the 26S proteasome for targeted protein degradation. The work aims to broaden the chemical toolkit for druggable targets by linking disease proteins to proteasome-mediated disposal.